Vývoj prevalence karcinomů plic a hrtanu v krajích ČR
| Title in English | Trend of prevalence of lung cancer and larynx cancer in regions of the Czech Republic |
|---|---|
| Authors | |
| Year of publication | 2007 |
| Type | Article in Proceedings |
| Conference | Sborník XV. Západočeské pneumoonkologické dny |
| MU Faculty or unit | |
| Citation | |
| Field | Earth magnetism, geography |
| Keywords | cancer of lung and larynx; incidence; mortality; prevalence; geographical distribution; |
| Description | The absolute numbers of new cases of cancers and cancers in situ (dg. C00–D09) increased during 1989–2004 in the Czech Republic by 51%, of cancer mortality by 5% and of prevalence by 149%. The numbers of surviving cancer cases aged 0-85 years or more increased by 259,237 to 433,941 i.e. 4245.8 per 100.000 inhabitants. The share of persons of economically active age 35–64 years decreased during 15 years from 42% to 34% in men, from 48% to 43% in women, but absolutely increased in both sex by 92,194 to 171,366 surviving cancer cases in 2004. The total prevalence will reach 523.8 thousand in 2010 and almost 611 thousand cancers in 2015. The highest increasing of prevalence in 1989–2004 was exceeded in regions Praha, Jihomoravský, Moravskoslezský and Středočeský in neoplasms of urinary tract, prostate and testis, melanoma and skin, respiratory tract of women and digestive tract of men. From 162,012 surviving cases of nine diagnoses prevailed the early clinical stages in 2204 probably due to higher mortality of their advanced forms. Direct expenditures of public health insurance on cancer treatment increased from 2000 by 7,222 thousand million CZK, i.e. 6.2% of total health budgets and amounted to 9,013 thousand million CZK, i.e. 5.3% of total budgets in 2005, which represented the average expenditure 20,6 thousand CZK per cancer case. The expected prevalence will increase by 174.3 thousand cancers during the period 2005-2015 (of which 55 thousand aged 35-64 years) and will amount 611 thousand cases. Processed results may allow to improve healthcare in oncology and to create economic conditions without decreasing of healthcare quality. |
| Related projects: |